ADMT · OTC · SIC 3845: Electromedical & Electrotherapeutic Apparatus
117
SEC Filings
$0.069
Close 2026-05-29
1
Transcripts
Business Summary
COMPANY OVERVIEW The Company is a technology-based developer and manufacturer of diversified lines of products and derives revenue from the production and sale of electronics for medical devices and other applications; environmentally safe chemical products for industrial, medical and cosmetic uses; and, research, development, regulatory and engineering services. The Company is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. Our operations are condu...
guided expect to invest approximately $1.3 billion
outlook
ADMT
stated We expect positive economic opportunities for the industry and the American farmer to materialize, which should drive additional long-term investments through
outlook
ADMT
stated we expect will be an increasingly more constructive operating environment
outlook
ADMT
stated we expect robust ethanol export opportunities to continue driven by mandated markets
outlook
ADMT
stated we expect margin expansion to contribute to Nutrition's operating profit growth as we focus on higher-margin products and see the benefits of our portfolio op
outlook
ADMT
stated We expect a portion of the segment operating profit growth discussed to be offset by higher expenses year-over-year that reflect continued investment in R&D a
outlook
ADMT
stated we expect to invest approximately $1
outlook
ADMT
stated we expect crush margins in the first quarter of 2026 to be similar to the fourth quarter of 2025 as we have already booked a large portion of our first quarte
outlook
ADMT
stated we expect ethanol margins to be tempered by higher industry run rates
outlook
ADMT
stated we expect to be an increasingly constructive operating environment